Methods for detecting bcl-3 gene in human leukemias
US5149628A · kind A · utility
52Cited by
1References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 15, 1989 |
| Grant date | Sep 22, 1992 |
| Priority date | — |
| Expiry date | Nov 15, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/813
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Bcl-3 gene sequences can be used to monitor the success of chemotherapy and to detect minimal residual disease in patients having hematopoietic malignancies. Bcl-3 sequences can also be used to identify new cellular oncogenes involved in hematopoietic cell malignancies by taking advantage of their adjacency to the bcl-3 promoter. Particular nucleic acid probes and primers are also provided by the disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.